A recent report confirmed down-regulation of MEG3 in more than 70 cases of human HCC and found an association between low levels of MEG3 and poor clinical outcome with reduced overall and relapse-free survival (105). This evidence concerns the gene MEG3 and hepatocellular carcinoma.